Loading…
Lakefront Biotherapeutics NV is projected to rise to $40.23 by 2027, a +33% move from its current price of $30.27. LKFT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $29.95 | $30.29 | $30.63 | +0.06% |
| Jul 14 | $29.83 | $30.30 | $30.79 | +0.11% |
| Jul 15 | $29.74 | $30.32 | $30.91 | +0.17% |
| Jul 16 | $29.67 | $30.34 | $31.02 | +0.23% |
| Jul 17 | $29.61 | $30.36 | $31.12 | +0.29% |
| Jul 18 | $29.55 | $30.37 | $31.22 | +0.34% |
| Jul 19 | $29.51 | $30.39 | $31.30 | +0.40% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $29.51 | $30.39 | $31.30 | +0.40% |
| Week 2 | $29.26 | $30.51 | $31.82 | +0.80% |
| Week 3 | $29.11 | $30.63 | $32.24 | +1.21% |
| Week 4 | $28.99 | $30.76 | $32.63 | +1.61% |
| Week 5 | $28.90 | $30.88 | $32.99 | +2.02% |
| Week 6 | $28.84 | $31.00 | $33.33 | +2.42% |
| Week 7 | $28.79 | $31.13 | $33.66 | +2.83% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lakefront Biotherapeutics NV (LKFT) is a biotechnology company focused on oncology and immunology with operations in the United States and Europe. Its pipeline includes GLPG3667 in a phase 2 clinical trial for dermatomyositis and systemic lupus erythematosus, GLPG5101 a CD19 CAR-T product candidate in phase 1/2 for relapsed/refractory non-Hodgkin lymphoma, and GLPG5301 a BCMA CAR-T product candidate in phase 1/2 for relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.
It was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Lakefront Biotherapeutics NV trades under the symbol LKFT and operates in the Healthcare sector. The stock has a current price of $30.39 and a market capitalization of $2B, with a relative standing of rank 1998. These basics provide a snapshot of the company’s size and market visibility.
A major floor 14.4% below — a decisive break under it would weaken the trend.
The nearest floor, 9.9% below — buyers have tended to step in here.
Price is pressing into resistance (1.8% away) — a breakout level to watch.
A major ceiling 11.3% above — clearing it would confirm fresh momentum.
Key LKFT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LKFT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $30.52 | Sell | $30.40 | Sell |
| MA 10 | $30.17 | Buy | $30.12 | Buy |
| MA 20 | $29.45 | Buy | $29.60 | Buy |
| MA 50 | $28.46 | Buy | $29.17 | Buy |
| MA 100 | $29.81 | Buy | $29.68 | Buy |
| MA 200 | $31.31 | Sell | $30.23 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.29 | Neutral |
| Stoch RSI (14) | 39.62 | Neutral |
| CCI (20) | 75.66 | Neutral |
| Williams %R (14) | -27.41 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 4.20 | Buy |
| Bollinger %B (20,2) | 0.75 | Neutral |
| Stochastic %K (14) | 72.59 | Neutral |
| TRIX (15) | 0.26 | Buy |
| Awesome (5,34) | 1.71 | Buy |
| Ultimate (7,14,28) | 61.87 | Neutral |
| Momentum (10) | 1.43 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 30.76 | Sell |
| ADX (14) | 21.61 | Buy |
| ATR (14) | 0.31 | Info |
Technically, the stock shows a BULLISH sentiment at present. The RSI14 is 70, signaling strong upside momentum, while the 50-day simple moving average stands at $28.28 and the 200-day simple moving average at $31.37. Immediate support is located at $27.27 and resistance at $30.39, framing a recent 30-day trading range from $28.00 to $32.99.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $26.61 | $30.27 | $40.17 | 0% | Neutral | |
| $32.95 | $40.23 | $51.36 | +33% | Bullish | |
| $35.90 | $44.66 | $58.56 | +48% | Bullish | |
| $37.64 | $47.55 | $63.67 | +57% | Bullish | |
| $39.21 | $50.19 | $68.42 | +66% | Bullish | |
| $40.02 | $51.86 | $71.81 | +71% | Bullish | |
| $47.68 | $62.49 | $87.76 | +106% | Bullish | |
| $55.37 | $73.33 | $104.31 | +142% | Bullish | |
| $56.37 | $75.39 | $108.53 | +149% | Bullish | |
| $61.67 | $83.26 | $121.19 | +175% | Bullish | |
| $88.36 | $124.42 | $189.79 | +311% | Bullish | |
| $141.82 | $214.19 | $350.22 | +608% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $26.61 | $30.27 | $36.03 | +0.00% |
| August 2026 | $26.92 | $31.51 | $37.70 | +4.11% |
| September 2026 | $27.11 | $31.89 | $38.44 | +1.18% |
| October 2026 | $26.55 | $31.35 | $38.04 | -1.67% |
| November 2026 | $26.75 | $31.70 | $38.68 | +1.11% |
| December 2026 | $27.55 | $32.76 | $40.17 | +3.34% |
Click any year to see its month-by-month LKFT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Lakefront Biotherapeutics NV's 2026 outlook centres on $30.27, within a $26.61 to $40.17 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, LKFT could reach as high as $51.36, with a base case around $40.23 and support toward $32.95 — roughly +33% from $30.27. Buyers look set to stay in control over this stretch.
Expect LKFT to range from $35.90 to $58.56 through 2028. The $44.66 average target implies a +48% move from current prices. That is up +11% on the projected 2027 average. Momentum favours further upside here.
The LKFT price prediction for 2029 points to an average of $47.55 (low $37.64, high $63.67) — a potential gain of +57% on today's $30.27. Buyers look set to stay in control over this stretch.
In 2030, LKFT is projected to trade between $39.21 and $68.42, averaging $50.19 — a potential gain of +66% from today's $30.27. That is up +6% on the projected 2029 average. Momentum favours further upside here.
Lakefront Biotherapeutics NV's 2031 outlook centres on $51.86, within a $40.02 to $71.81 range. That is up +3% on the projected 2030 average. That marks a +71% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, LKFT could reach as high as $87.76, with a base case around $62.49 and support toward $47.68 — roughly +106% from $30.27. Momentum favours further upside here.
Expect LKFT to range from $55.37 to $104.31 through 2033. The $73.33 average target implies a +142% move from current prices. That is up +17% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The LKFT price prediction for 2034 points to an average of $75.39 (low $56.37, high $108.53) — a potential gain of +149% on today's $30.27. Momentum favours further upside here.
In 2035, LKFT is projected to trade between $61.67 and $121.19, averaging $83.26 — a potential gain of +175% from today's $30.27. That is up +10% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Lakefront Biotherapeutics NV's 2040 outlook centres on $124.42, within a $88.36 to $189.79 range. That is up +49% on the projected 2035 average. That marks a +311% change versus current levels. Momentum favours further upside here.
By 2050, LKFT could reach as high as $350.22, with a base case around $214.19 and support toward $141.82 — roughly +608% from $30.27. Buyers look set to stay in control over this stretch.
Investing $1,000 in LKFT today (≈ 33.036009 LKFT) could be worth
$7,075.85
+$6,075.85 (+608%) by 2050 · US Dollar
Based on the average projected LKFT price of $214.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LKFTwould be worth at today's price.
$1,000 invested in LKFT on Jul 10, 2025 (≈ 32.797639 LKFT) would be worth
$992.78
-$7.22 (-0.7%) today · 0.99× · US Dollar
Based on a LKFT entry price of $30.49 vs. today's $30.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $30.39 | $996.05 | -0.4% |
| 1 month ago | $28.61 | $1,058.02 | +5.8% |
| 3 months ago | $28.4 | $1,065.85 | +6.6% |
| 6 months ago | $33.11 | $914.23 | -8.6% |
| 1 year ago | $30.49 | $992.78 | -0.7% |
| All time (5.0y) ago | $67 | $451.79 | -54.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LKFT forecast.
Our base-case forecast reaches $61.00 around 2032.
Implied market cap at $61.00: $4B
The multi-year forecast outlines a progressive march higher, with the 2026 average price at $30.39 and a 2026 range of $26.61 to $40.66. By 2027 the average price rises to $40.49 with a max of $51.72, yielding a 33.2% implied return, and the outlook remains bullish through 2035 with the averages climbing to $85.28 at 2035 and then extending into 2040 at an average of $128.68 (max $196.32) and a 323.4% implied return. The 2050 forecast shows an average of $221.69 with a max of $362.54, implying a 629.5% implied return and a sustained bullish sentiment.
Drivers cited by the forecast include ongoing clinical-stage programs across oncology and immunology and collaboration with Gilead, though all figures are estimates and carry uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $50.63 with a range from $39.54 to $69.04 and a 66.6% ROI, with bullish sentiment.
Forecasts indicate a bullish trajectory from 2027 onward, with rising averages and ROI reaching 66.6% by 2030 and 629.5% by 2050, though 2026 is shown as neutral and forecasts are not guarantees.
Yes, the 2040 forecast max is $196.32 (just under $200) and the 2050 max is $362.54, indicating the potential to exceed $200 by 2050.
The stock shows a BULLISH technical picture with RSI14 at 70, SMA50 at $28.28, SMA200 at $31.37, support at $27.27, and resistance at $30.39, with a 30-day range of $28.00 to $32.99.
The current price is $30.39 and the market cap is $2B, with a rank of 1998.
Lakefront Biotherapeutics NV Community Discussion
0Share your Lakefront Biotherapeutics NV price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.